Free Trial

Medical Properties Trust (MPW) to Release Quarterly Earnings on Thursday

Medical Properties Trust logo with Finance background

Medical Properties Trust (NYSE:MPW - Get Free Report) is scheduled to be releasing its earnings data before the market opens on Thursday, November 7th. Analysts expect Medical Properties Trust to post earnings of $0.20 per share for the quarter. Investors that wish to listen to the company's conference call can do so using this link.

Medical Properties Trust (NYSE:MPW - Get Free Report) last posted its earnings results on Thursday, August 8th. The real estate investment trust reported ($0.54) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.21 by ($0.75). The company had revenue of $266.60 million during the quarter, compared to analysts' expectations of $259.53 million. The company's quarterly revenue was down 21.0% compared to the same quarter last year. During the same quarter last year, the firm posted $0.48 earnings per share. On average, analysts expect Medical Properties Trust to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Medical Properties Trust Stock Down 1.5 %

Shares of Medical Properties Trust stock traded down $0.07 during trading on Thursday, hitting $4.64. 7,412,666 shares of the stock were exchanged, compared to its average volume of 17,038,922. Medical Properties Trust has a 12-month low of $2.92 and a 12-month high of $6.55. The stock has a market cap of $2.78 billion, a price-to-earnings ratio of -1.73, a price-to-earnings-growth ratio of 0.68 and a beta of 1.29. The company has a debt-to-equity ratio of 1.51, a current ratio of 2.93 and a quick ratio of 2.93. The firm's 50-day moving average price is $5.15 and its 200 day moving average price is $4.93.

Medical Properties Trust Cuts Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, October 10th. Shareholders of record on Monday, September 9th were given a dividend of $0.08 per share. This represents a $0.32 annualized dividend and a yield of 6.90%. The ex-dividend date of this dividend was Monday, September 9th. Medical Properties Trust's dividend payout ratio (DPR) is -11.90%.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the stock. Wolfe Research raised shares of Medical Properties Trust to a "hold" rating in a report on Monday, September 23rd. Colliers Securities upgraded Medical Properties Trust from a "neutral" rating to a "buy" rating and set a $6.50 price target for the company in a research report on Friday, September 13th. Finally, Truist Financial upped their target price on Medical Properties Trust from $5.00 to $6.00 and gave the company a "hold" rating in a research note on Friday, September 13th. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and one has given a buy rating to the company. According to MarketBeat.com, Medical Properties Trust currently has a consensus rating of "Hold" and a consensus target price of $5.38.

Get Our Latest Analysis on Medical Properties Trust

Insider Activity at Medical Properties Trust

In related news, Director C Reynolds Thompson III sold 20,530 shares of the business's stock in a transaction that occurred on Tuesday, August 27th. The shares were sold at an average price of $4.38, for a total transaction of $89,921.40. Following the transaction, the director now directly owns 54,637 shares of the company's stock, valued at approximately $239,310.06. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, Director Elizabeth N. Pitman acquired 8,087 shares of Medical Properties Trust stock in a transaction dated Wednesday, September 18th. The stock was acquired at an average cost of $6.01 per share, for a total transaction of $48,602.87. Following the completion of the purchase, the director now owns 76,740 shares of the company's stock, valued at $461,207.40. This represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Also, Director C Reynolds Thompson III sold 20,530 shares of Medical Properties Trust stock in a transaction on Tuesday, August 27th. The stock was sold at an average price of $4.38, for a total transaction of $89,921.40. Following the completion of the transaction, the director now owns 54,637 shares in the company, valued at $239,310.06. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 63,335 shares of company stock valued at $318,825 over the last 90 days. 1.53% of the stock is currently owned by corporate insiders.

Medical Properties Trust Company Profile

(Get Free Report)

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.

See Also

Earnings History for Medical Properties Trust (NYSE:MPW)

Should you invest $1,000 in Medical Properties Trust right now?

Before you consider Medical Properties Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medical Properties Trust wasn't on the list.

While Medical Properties Trust currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines